BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of xenobiotics
,
Leukemia
,
Leukocyte
,
Alcohol
,
Lipopolysaccharide
,
SLC12A1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Shiga toxin
Summary
General Info
Curated Studies
Most Correlated Studies
Microvascular endothelial cells response to Shiga toxins
Shiga toxin-induced gene expression in THP-1 monocytic leukemia cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Differential induction of Shiga toxin in environmental Escherichia coli O145:H28 strains carrying th…
Mechanism for inhibition of cytotoxicity of Shiga toxin by luteolin.
Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.
Shiga toxin (Stx) type 2-induced increase in O-linked N-acetyl glucosamine protein modification: a n…
The Protein Toxins Ricin and Shiga Toxin as Tools to Explore Cellular Mechanisms of Internalization …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion
Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU
Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic S…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ